Skip to content
naulon
Not checkedNot checked for notices yet.

Moving ahead of prostate-specific antigen

Banyameen Mohamad Iqbal, Mushtaq Ahmed Peer

Medical Journal of Dr. D.Y. Patil University · 2016

doi:10.4103/0975-2870.186079 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Prostate gland is the second most leading site of cancer among males in Indian cities and it is the second most common site of cancer among US men. Prostate cancer (PCa) is the sixth leading cause of cancer death among men worldwide. The worldwide PCa burden is expected to grow to 1.7 million new cases and 499,000 new deaths by 2030. Prostate specific antigen (PSA) is a protein made by the prostate. Biochemically, it belongs to the protease family of kallikrein and is also known as human kallikrein 3. PSA test was originally approved by the Food and Drug Administration in 1986 to monitor the progression of PCa in men who had already been diagnosed with the disease. PSA test is a nonspecific test for PCa. It can be raised in a number of benign conditions of the prostate as well. The most frequent benign prostate conditions that cause an elevation in PSA level is prostatitis and benign prostatic hyperplasia. Moreover, PSA test may give false-positive or false-negative results. Scientists and researchers are experimenting new ways to improve the PSA test to give us the ability to distinguish cancerous from benign conditions. Some new methods/genetic studies such as PCa gene 3, TMPRSS2-ERG fusion gene, micro ribonucleic acid patterns, proteo-imaging, etc., are being developed to detect PCa in its earliest form. These new tests are much more sensitive and specific than the age old PSA test. It is only a matter of time when these new tests will be fully functional and will either augment or fully replace the age old PSA test.

Abstract licence: CC BY-NC-SA

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.